Applied Therapeutics, Inc.
General ticker "APLT" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $138.1M (TTM average)
Applied Therapeutics, Inc. follows the US Stock Market performance with the rate: 22.7%.
Estimated limits based on current volatility of 2.4%: low 0.24$, high 0.25$
Factors to consider:
- Total employees count: 25 (-7.4%) as of 2023
- Top business risk factors: Operating losses, Key executive dependency, Clinical trial failures, Insufficient funding, Regulatory and compliance
- Current price 75.4% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.94$, 3.20$]
- 2025-12-31 to 2026-12-31 estimated range: [0.71$, 2.32$]
Financial Metrics affecting the APLT estimates:
- Positive: with PPE of -5.2 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -67.05 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Positive: Investing cash flow per share per price, % of 0 > -0.66
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: Shareholder equity ratio, % of 65.76 > 63.39
- Negative: negative Net income
Short-term APLT quotes
Long-term APLT plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $9.99MM | $0.46MM |
| Operating Expenses | $82.95MM | $74.53MM | $104.75MM |
| Operating Income | $-82.95MM | $-64.53MM | $-104.30MM |
| Non-Operating Income | $0.44MM | $-55.23MM | $-1.32MM |
| R&D Expense | $55.63MM | $53.91MM | $48.74MM |
| Income(Loss) | $-82.51MM | $-119.76MM | $-105.62MM |
| Profit(Loss)* | $-82.51MM | $-119.76MM | $-105.62MM |
| Stockholders Equity | $4.06MM | $-17.15MM | $57.01MM |
| Inventory | $0.00MM | $3.28MM | $0.00MM |
| Assets | $38.36MM | $54.83MM | $86.69MM |
| Operating Cash Flow | $-78.09MM | $-55.17MM | $-84.31MM |
| Investing Cash Flow | $13.17MM | $13.87MM | $0.00MM |
| Financing Cash Flow | $27.69MM | $74.54MM | $113.81MM |
| Earnings Per Share** | $-2.18 | $-1.42 | $-0.76 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.